Subject
Pharmacology (medical),Pharmacology
Reference55 articles.
1. Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation.;Ariga;J. Immunol.,2004
2. Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.;Armani;J. Med. Chem.,2014
3. Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond.;Baillie;Nat. Rev. Drug. Discov.,2019
4. Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.;Bjermer;Pulm. Pharmacol. Ther.,2019
5. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one].;Boswell-Smith;J. Pharmacol. Exp. Ther.,2006
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献